These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9009097)

  • 61. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Futaki M; Dan K; Nomura T
    Intern Med; 1994 Apr; 33(4):189-92. PubMed ID: 7520786
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Detection of bcr/abl fusion gene in chronic myeloid leukemia by fluorescence in situ hybridization and nested reverse transcription polymerase chain reaction].
    Wu B; Zhou SY; Liu XL; Song LL; Zhang Y
    Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):235-7. PubMed ID: 12859872
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Co-detection of chimeric bcr/abl (target) and beta-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction.
    Wisniewski D; Strife A; Clarkson B
    Leuk Res; 1991; 15(9):867-74. PubMed ID: 1921462
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predominantly BCR-ABL negative myeloid precursors in interferon-alpha treated chronic myelogenous leukemia: a follow-up study of peripheral blood colony-forming cells with fluorescence in situ hybridization.
    Sick C; Schultheis B; Pasternak G; Kottke I; Hörner S; Heissig B; Hehlmann R
    Ann Hematol; 2001 Jan; 80(1):9-16. PubMed ID: 11233781
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis.
    Selleri C; Maciejewski JP; Pane F; Luciano L; Raiola AM; Mostarda I; Salvatore F; Rotoli B
    Blood; 1998 Aug; 92(3):981-9. PubMed ID: 9680367
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
    Jazwiec B; Mahon FX; Pigneux A; Pigeonnier V; Reiffers J
    Exp Hematol; 1995 Dec; 23(14):1509-14. PubMed ID: 8542939
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clonal analysis of granulocyte-monocyte colony-forming unit cells with the human androgen receptor gene in chronic myeloid leukemia.
    Akel S; Mavroyanni D; Yataganas X; Terpos E; Meletis J; Anargyrou K; Stavrogianni N; Pangalis GA; Loukopoulos D; Viniou N
    Int J Hematol; 2003 Jun; 77(5):476-81. PubMed ID: 12841386
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Successful mafosfamide purging of bone marrow from chronic myelogenous leukemia (CML) cells.
    Nieborowska-Skórska M; Skórski T; Ratajczak MZ; Szczylik C; Malaguarnera L; Calabretta B
    Folia Histochem Cytobiol; 1993; 31(4):161-7. PubMed ID: 8137996
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; van der Hem KG; Odding JH; Dräger AM; Ossenkoppele GJ
    Br J Cancer; 1999 Mar; 79(9-10):1406-12. PubMed ID: 10188883
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?
    Pasternak G; Schultheis B; Heissig B; Hörner S; Sick C; Hehlmann R
    Leukemia; 1999 Apr; 13 Suppl 1():S55-64. PubMed ID: 10232367
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant.
    Carrara RC; Orellana MD; Fontes AM; Palma PV; Kashima S; Mendes MR; Coutinho MA; Voltarelli JC; Covas DT
    Braz J Med Biol Res; 2007 Jan; 40(1):57-67. PubMed ID: 17224997
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
    Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
    Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of gemcitabine on granulocyte colony-stimulating factor receptor and bcr/abl mRNA in patients with chronic myeloid leukemia].
    Liu D; Wang F; Sun L; Liu LX; Liu YF; Ling Z; Han XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1168-71. PubMed ID: 21129254
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
    Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
    J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
    Guo JQ; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus RB
    Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.